Literature DB >> 21300356

Diabetes and the risk of coronary heart disease in the general Japanese population: the Japan Public Health Center-based prospective (JPHC) study.

Isao Saito1, Yoshihiro Kokubo, Kazumasa Yamagishi, Hiroyasu Iso, Manami Inoue, Shoichiro Tsugane.   

Abstract

OBJECTIVE: Although diabetes has a great impact on coronary heart disease (CHD) in Western populations, there is limited evidence that diabetes influences CHD in the Japanese population.
METHODS: The Japan Public Health Center-based prospective (JPHC) study conducted a follow-up of 31,192 individuals aged 40-69 years with no history of cardiovascular disease or cancer. Subjects were classified at baseline as normal, borderline diabetic or diabetic based on fasting and non-fasting blood glucose levels and the use of medication to treat diabetes. A Cox proportional hazards model was used to determine the association between diabetes and the risk of fatal and non-fatal CHD events after adjustment for potential confounders.
RESULTS: During 12.9 years of follow-up (1990-2006), we identified 266 fatal and non-fatal coronary events using validated criteria. With normal individuals serving as a control, the hazard ratios for total incident CHD events after adjusting for sex, age, study community and fasting were 1.65 (95% CI, 1.19-2.29) and 3.05 (2.03-4.59) in the borderline and diabetic groups, respectively. These associations remained significant after adjustment for conventional risk factors. The population attributable fractions (PAF) of borderline diabetes and diabetes for CHD events were 6.9% and 6.3%, respectively. Furthermore, there was a trend for an association between an impaired fasting glucose (5.6-6.9 mmol/l) and an increased risk of CHD events.
CONCLUSIONS: This prospective study suggests that diabetes and elevated glucose levels are associated with incident CHD in the general Japanese population. The PAF of diabetes for fatal and non-fatal coronary events was estimated to be moderate.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300356     DOI: 10.1016/j.atherosclerosis.2011.01.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Shadow of diabetes over cardiovascular disease: comparative quantification of population-attributable all-cause and cardiovascular mortality.

Authors:  Mohammadreza Bozorgmanesh; Farzad Hadaegh; Farhad Sheikholeslami; Arash Ghanbarian; Fereidoun Azizi
Journal:  Cardiovasc Diabetol       Date:  2012-06-15       Impact factor: 9.951

3.  Risk of hospitalization for diabetic macrovascular complications and in-hospital mortality with irregular physician visits using propensity score matching.

Authors:  Takumi Nishi; Akira Babazono; Toshiki Maeda
Journal:  J Diabetes Investig       Date:  2013-12-04       Impact factor: 4.232

4.  Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan.

Authors:  Atsushi Goto; Mitsuhiko Noda; Yumi Matsushita; Maki Goto; Masayuki Kato; Akihiro Isogawa; Yoshihiko Takahashi; Kayo Kurotani; Shino Oba; Akiko Nanri; Tetsuya Mizoue; Kazumasa Yamagishi; Hiroshi Yatsuya; Isao Saito; Yoshihiro Kokubo; Norie Sawada; Manami Inoue; Hiroyasu Iso; Takashi Kadowaki; Shoichiro Tsugane
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 5.  Atherosclerotic Cardiovascular Risk in Japan.

Authors:  Shuko Nojiri; Hiroyuki Daida
Journal:  Jpn Clin Med       Date:  2017-06-19

6.  Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?

Authors:  Yoshihiro Kokubo
Journal:  EPMA J       Date:  2011-04-02       Impact factor: 6.543

7.  High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25-64 Years Old Iranian Population.

Authors:  Niloofar Peykari; Moghaddam Sahar Saeedi; Shirin Djalalinia; Amir Kasaeian; Ali Sheidaei; Anita Mansouri; Younes Mohammadi; Mahboubeh Parsaeian; Parinaz Mehdipour; Bagher Larijani; Farshad Farzadfar
Journal:  Int J Prev Med       Date:  2016-05-19

8.  Association of the Estimated Coronary Artery Incidence Risk According to the Japan Atherosclerosis Society Guidelines 2017 with Cardio-Ankle Vascular Index.

Authors:  Mizuki Sata; Tomonori Okamura; Sei Harada; Daisuke Sugiyama; Kazuyo Kuwabara; Aya Hirata; Ayano Takeuchi; Miho Iida; Suzuka Kato; Minako Matsumoto; Ayako Kurihara; Toru Takebayashi
Journal:  J Atheroscler Thromb       Date:  2021-03-06       Impact factor: 4.928

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.